Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Transocean Ltd | Thigpen D. Jeremy | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 1,935,353 | 5,393,945 (0%) | 0% | 0 | Registered Shares | |
| HF Sinclair Corp | Carol Orme-Holding | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 56.50 per share. | 08 Feb 2024 | 1,061,946 | 26,406,134 (16%) | 0% | 56.5 | 59,999,949 | Common Stock |
| Snap Inc (Class A) | Robert Murphy | Director, Chief Technology Officer, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 10.96 per share. | 08 Feb 2024 | 1,000,000 | 66,234,408 (5%) | 0% | 11.0 | 10,964,600 | Class A Common Stock |
| Transocean Ltd | Thigpen Jeremy D. | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.08 per share. | 08 Feb 2024 | 784,010 | 4,609,935 (0%) | 0% | 5.1 | 3,982,771 | Registered Shares |
| Lexicon Pharma Inc | Lonnel Coats | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 770,420 | 770,420 | - | - | Restricted Stock Units | |
| Lexicon Pharma Inc | Lonnel Coats | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 770,420 | 770,420 | - | - | Stock Option (Right to Buy) | |
| Transocean Ltd | Jeremy Thigpen D. | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 736,920 | 736,920 | - | - | Restricted Units | |
| Sana biotech Inc | Taylor Nelsen Robert | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.50 per share. | 08 Feb 2024 | 727,272 | 12,446,022 | - | 5.5 | 3,999,996 | Common Stock |
| Sana biotech Inc | Nelsen Robert Taylor | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.50 per share. | 08 Feb 2024 | 727,272 | 12,446,022 | - | 5.5 | 3,999,996 | Common Stock |
| Transocean Ltd | L. Mark Mey | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 696,727 | 1,681,044 (0%) | 0% | 0 | Registered Shares | |
| DraftKings Inc (Class A) | Stanton Dodge R. | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 43.06 per share. | 08 Feb 2024 | 686,101 | 200,239 | - | 43.1 | 29,543,509 | Class A Common Stock |
| Meta | Zuckerberg Mark | Director, COB and CEO, Ten Percent Owner | 08 Feb 2024 | 669,493 | 295,885,026 | - | - | Class B Common Stock | ||
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 08 Feb 2024 | 669,493 | 669,493 (0%) | 0% | 0 | Class A Common Stock | ||
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Feb 2024 | 638,000 | 31,493 (0%) | 0% | 0 | Class A Common Stock | |
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Feb 2024 | 638,000 | 638,000 (0%) | 0% | 0 | Class A Common Stock | |
| Transocean Ltd | Adamson Keelan | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 587,055 | 1,069,868 (0%) | 0% | 0 | Registered Shares | |
| Zurn Elkay Water Soln Corp | Adams Todd A. | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 586,432 | 2,414,586 (1%) | 0% | - | Common Stock | |
| Transocean Ltd | E Howard Davis | EVP, CAO & CIO | 08 Feb 2024 | 554,801 | 1,479,407 (0%) | 0% | 0 | Registered Shares | ||
| Enterprise Products Partners L P - Unit | Randa Williams Duncan | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 550,000 | 550,000 | - | - | Phantom Units | |
| Astria Therapeutics Inc | Milne C. Jill | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 534,600 | 534,600 | - | - | Stock Option (Right to Buy) | |
| Transocean Ltd | Brady Long | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 516,094 | 1,473,027 (0%) | 0% | 0 | Registered Shares | |
| DraftKings Inc (Class A) | Robins D. Jason | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 43.06 per share. | 08 Feb 2024 | 450,000 | 3,373,637 | - | 43.1 | 19,377,000 | Class A Common Stock |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 421,250 | 421,250 | - | - | Stock Options (Right to buy) | |
| Palantir | Sankar Shyam | See Remarks | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 08 Feb 2024 | 418,936 | 752,786 | - | 25.0 | 10,475,411 | Class A Common Stock |
| Palantir | Sankar Shyam | See Remarks | 08 Feb 2024 | 418,936 | 1,171,722 | - | - | Class A Common Stock | ||
| Palantir | Shyam Sankar | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 418,936 | 118,352 | - | - | Employee Stock Option (Right to buy) | |
| Palantir | Sankar Shyam | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 418,936 | 2,342,461 | - | - | Class B Common Stock | |
| Palantir | Shyam Sankar | See Remarks | 08 Feb 2024 | 418,936 | 1,923,525 | - | - | Class B Common Stock | ||
| Enterprise Products Partners L P - Unit | H. Bachmann Richard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 400,000 | 400,000 | - | - | Phantom Units | |
| GoPro Inc (Class A) | Woodman Nicholas | Director, CEO, Chairman of the Board, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 374,196 | 959,892 (0%) | 0% | 0 | Class A Common Stock | |
| Sana biotech Inc | Taylor Robert Nelsen | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.50 per share. | 08 Feb 2024 | 363,637 | 10,667,387 | - | 5.5 | 2,000,004 | Common Stock |
| Palantir | David Glazer | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 360,000 | 66,169 | - | - | Employee Stock Option (Right to buy) | |
| Palantir | David Glazer | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.72 per share. | 08 Feb 2024 | 360,000 | 364,344 | - | 4.7 | 1,699,200 | Class A Common Stock |
| Palantir | David Glazer | See Remarks | Sale of securities on an exchange or to another person at price $ 24.74 per share. | 08 Feb 2024 | 360,000 | 4,344 | - | 24.7 | 8,904,888 | Class A Common Stock |
| Carrier Global | David L. Gitlin | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 54.16 per share. | 08 Feb 2024 | 354,539 | 422,808 | - | 54.2 | 19,203,073 | Common Stock |
| Transocean Ltd | Tonnel David A. | SVP - CHIEF ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 345,780 | 763,569 (0%) | 0% | 0 | Registered Shares | |
| Carrier Global | David L. Gitlin | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 320,042 | 0 | - | - | Stock Appreciation Right | |
| Carrier Global | David Gitlin L. | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.43 per share. | 08 Feb 2024 | 320,042 | 800,850 | - | 21.4 | 6,858,500 | Common Stock |
| Lexicon Pharma Inc | L. Wade Jeffrey | President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 314,320 | 314,320 | - | - | Restricted Stock Units | |
| Lexicon Pharma Inc | Wade L. Jeffrey | President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 314,320 | 314,320 | - | - | Stock Option (Right to Buy) | |
| Transocean Ltd | Adamson Keelan | PRESIDENT AND COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 313,191 | 313,191 | - | - | Restricted Units | |
| Enterprise Products Partners L P - Unit | James Teague A. | Director, CO-CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 310,000 | 310,000 | - | - | Phantom Units | |
| Enterprise Products Partners L P - Unit | Fowler Randall W. | Director, CO-CEO AND CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 310,000 | 310,000 | - | - | Phantom Units | |
| Snap Inc (Class A) | Robert Murphy | Director, Chief Technology Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Feb 2024 | 294,745 | 65,939,663 (5%) | 0% | 0 | Class A Common Stock | |
| Transocean Ltd | Mey Mark L. | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.08 per share. | 08 Feb 2024 | 282,243 | 1,398,801 (0%) | 0% | 5.1 | 1,433,794 | Registered Shares |
| Zurn Elkay Water Soln Corp | Adams A. Todd | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 32.19 per share. | 08 Feb 2024 | 277,571 | 2,137,015 (1%) | 0% | 32.2 | 8,935,010 | Common Stock |
| Transocean Ltd | L. Mey Mark | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 248,710 | 248,710 | - | - | Restricted Units | |
| Macrogenics Inc | Scott Koenig | Director, President and CEO | 08 Feb 2024 | 248,000 | 248,000 | - | - | Employee Stock Option (right to buy) | ||
| RTX | T. Christopher Calio | Director, President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 247,200 | 247,200 | - | - | Stock Appreciation Right | |
| Immuneering Corp (Class A) | Zeskind Benjamin J. | Director, PRESIDENT AND CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 244,286 | 244,286 | - | - | Stock Option | |
| Transocean Ltd | Adamson Keelan | PRESIDENT AND COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.08 per share. | 08 Feb 2024 | 237,828 | 832,040 (0%) | 0% | 5.1 | 1,208,166 | Registered Shares |
| Lexicon Pharma Inc | Garner Thomas | SVP, Chief Commercial Officer | 08 Feb 2024 | 227,130 | 227,130 | - | - | Restricted Stock Units | ||
| Lexicon Pharma Inc | Garner Thomas | SVP, Chief Commercial Officer | 08 Feb 2024 | 227,130 | 227,130 | - | - | Stock Option (Right to Buy) | ||
| Travelers Companies | D. Schnitzer Alan | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 222,901 | 0 | - | - | Stock Options (Right to Buy) | |
| Travelers Companies | Alan D. Schnitzer | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 118.78 per share. | 08 Feb 2024 | 222,901 | 445,424 (0%) | 0% | 118.8 | 26,476,181 | Common Stock |
| Lexicon Pharma Inc | Granowitz B. Craig | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 222,680 | 222,680 | - | - | Restricted Stock Units | |
| Lexicon Pharma Inc | Craig B. Granowitz | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 222,680 | 222,680 | - | - | Stock Option (Right to Buy) | |
| Alkermes PLC | F. Richard Pops | Director, Director and CEO, Alkermes plc | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 218,551 | 1,271,432 (0%) | 0% | - | Ordinary Shares | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 210,625 | 210,625 | - | - | Restricted Stock Units | |
| Transocean Ltd | Howard Davis E | EVP, CAO & CIO | 08 Feb 2024 | 209,004 | 1,270,403 (0%) | 0% | 5.1 | 1,061,740 | Registered Shares | |
| Lexicon Pharma Inc | Crum Brian T. | SVP, General Counsel & Secr. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 208,160 | 208,160 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharma Inc | T. Crum Brian | SVP, General Counsel & Secr. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 208,160 | 208,160 | - | - | Restricted Stock Units | |
| Lexicon Pharma Inc | Main J. Alan | EVP, Innov & Chem Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 204,730 | 204,730 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharma Inc | J. Main Alan | EVP, Innov & Chem Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 204,730 | 204,730 | - | - | Restricted Stock Units | |
| Lexicon Pharma Inc | B. Kenneth Kassler-Taub | SVP, Regulatory & QA | 08 Feb 2024 | 203,810 | 203,810 | - | - | Stock Option (Right to Buy) | ||
| Lexicon Pharma Inc | Kenneth B. Kassler-Taub | SVP, Regulatory & QA | 08 Feb 2024 | 203,810 | 203,810 | - | - | Restricted Stock Units | ||
| Transocean Ltd | Brady Long | EVP & GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 200,978 | 200,978 | - | - | Restricted Units | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 199,973 | 529,401 | - | - | Common Stock | |
| Transocean Ltd | E Howard Davis | EVP, CAO & CIO | 08 Feb 2024 | 198,047 | 198,047 | - | - | Restricted Units | ||
| Alliance Resource Partners, LP - Unit | Kirk Tholen | SENIOR VICE PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 198,020 | 198,020 (0%) | 0% | - | Common unit | |
| Alliance Resource Partners, LP - Unit | Tholen Kirk | SENIOR VICE PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 198,020 | 0 | - | - | Restricted unit | |
| Priority Technology Holdings | Thomas Charles Priore | Director, President, CEO and Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 191,693 | 0 | - | - | Restricted Stock Unit | |
| Biodesix Inc | Scott Hutton | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 187,761 | 563,281 | - | - | Restricted Stock Units | |
| RTX | Hayes Gregory J. | Director, Chairman and CEO | 08 Feb 2024 | 183,100 | 183,100 | - | - | Stock Appreciation Right | ||
| Transocean Ltd | Brady Long | EVP & GENERAL COUNSEL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.08 per share. | 08 Feb 2024 | 179,546 | 1,293,481 (0%) | 0% | 5.1 | 912,094 | Registered Shares |
| Kenvue | Mongon Thibaut | Director, Chief Executive Officer | 08 Feb 2024 | 179,515 | 0 | - | - | Restricted Stock Units | ||
| Kenvue | Thibaut Mongon | Director, Chief Executive Officer | 08 Feb 2024 | 179,515 | 179,515 | - | 0 | Common Stock | ||
| Travelers Companies | D. Alan Schnitzer | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 213.46 per share. | 08 Feb 2024 | 178,005 | 222,523 (0%) | 0% | 213.5 | 37,996,947 | Common Stock |
| Carrier Global | L. Gitlin David | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.06 per share. | 08 Feb 2024 | 176,730 | 777,347 | - | 54.1 | 9,554,024 | Common Stock |
| Astria Therapeutics Inc | Morabito Christopher | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Astria Therapeutics Inc | Noah Clauser | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Astria Therapeutics Inc | Matthews Andrea | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Astria Therapeutics Inc | Benjamin Harshbarger | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Astria Therapeutics Inc | Andrew Komjathy | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| RTX | Hayes Gregory J. | Director, Chairman and CEO | 08 Feb 2024 | 171,629 | 621,894 (0%) | 0% | 91.0 | 15,625,104 | Common Stock | |
| nVent Electric PLC | Beth A. Wozniak | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 64.21 per share. | 08 Feb 2024 | 169,147 | 29,406 (0%) | 0% | 64.2 | 10,860,946 | Ordinary Shares |
| Zurn Elkay Water Soln Corp | Mark Peterson W. | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 162,396 | 464,695 (0%) | 0% | - | Common Stock | |
| Lexicon Pharma Inc | E. McDermott Wendy | VP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 156,950 | 156,950 | - | - | Restricted Stock Units | |
| Lexicon Pharma Inc | E. Wendy McDermott | VP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 156,950 | 156,950 | - | - | Stock Option (Right to Buy) | |
| Vornado Realty Trust | Roth Steven | Director, CHAIRMAN AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 154,154 | 154,154 | - | - | LTIP Units | |
| Snap Inc (Class A) | Evan T. Spiegel | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.11 per share. | 08 Feb 2024 | 150,000 | 3,627,844 (0%) | 0% | 11.1 | 1,666,530 | Class A Common Stock |
| Warrior Met Coal Inc | Scheller Walter | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 142,052 | 414,914 (0%) | 0% | 0 | Common Stock | |
| Weyerhaeuser | Devon W. Stockfish | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 140,744 | 853,610 (0%) | 0% | 0 | Common | |
| Transocean Ltd | Tonnel A. David | SVP - CHIEF ACCOUNTING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.08 per share. | 08 Feb 2024 | 140,084 | 623,485 (0%) | 0% | 5.1 | 711,627 | Registered Shares |
| Viking Therapeutics Inc | Brian Lian | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.65 per share. | 08 Feb 2024 | 140,000 | 2,404,882 (3%) | 0% | 4.7 | 651,000 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Brian Lian | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 140,000 | 0 | - | - | Stock Option (right to buy) | |
| Alliance Resource Partners, LP - Unit | Thomas Wynne M. | SENIOR VICE PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 138,610 | 921,863 (0%) | 0% | - | Common unit | |
| Alliance Resource Partners, LP - Unit | M. Thomas Wynne | SENIOR VICE PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 138,610 | 0 | - | - | Restricted unit | |
| Transocean Ltd | Tonnel David A. | SVP - CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 135,777 | 135,777 | - | - | Restricted Units | |
| Immuneering Corp (Class A) | Hall Brett | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 130,900 | 130,900 | - | - | Stock Option | |
| Zurn Elkay Water Soln Corp | Adams Todd A. | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 33.06 per share. | 08 Feb 2024 | 129,604 | 1,828,550 (1%) | 0% | 33.1 | 4,284,708 | Common Stock |
| Biodesix Inc | Gary Pestano | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 128,761 | 128,761 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | Harper Cowie Robin | CFO, Secy & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 128,761 | 128,761 | - | - | Stock Options (Right to buy) | |
| Biodesix Inc | O’Kane Kieran | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 128,761 | 128,761 | - | - | Stock Options (Right to buy) | |
| Bowman Consulting Grp Ltd | Bowman Gary | Director, President, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 128,245 | 1,099,151 | - | 0 | Common Stock | |
| Yum China Holdings Inc | Wat Joey | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 126,104 | 126,104 | - | - | Restricted Stock Unit | |
| Alliance Resource Partners, LP - Unit | R. Eberley Davis | SVP-LAW/ADMIN,GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 119,800 | 316,055 (0%) | 0% | - | Common unit | |
| Alliance Resource Partners, LP - Unit | Eberley R. Davis | SVP-LAW/ADMIN,GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 119,800 | 0 | - | - | Restricted unit | |
| Dover | Tobin J. Richard | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 116,587 | 116,587 | - | - | Stock Appreciation Right | |
| Weyerhaeuser | W. Stockfish Devon | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 114,751 | 968,361 (0%) | 0% | 0 | Common | |
| Calix Inc | Collins John Matthew | Chief Commercial Ops Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 109,000 | 109,000 | - | - | Stock Option (right to buy) | |
| Calix Inc | Shane Todd Marshall Eleniak | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 109,000 | 109,000 | - | - | Stock Option (right to buy) | |
| RTX | Neil Mitchill G. | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 100,700 | 100,700 | - | - | Stock Appreciation Right | |
| Amphenol (Class A) | Lampo A. Craig | SR VP & CFO | Sale of securities on an exchange or to another person at price $ 104.67 per share. | 08 Feb 2024 | 100,000 | 147,045 (0%) | 0% | 104.7 | 10,466,690 | Class A Common Stock |
| Amphenol (Class A) | A. Craig Lampo | SR VP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.99 per share. | 08 Feb 2024 | 100,000 | 247,045 (0%) | 0% | 29.0 | 2,899,000 | Class A Common Stock |
| Amphenol (Class A) | A. Craig Lampo | SR VP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 100,000 | 200,000 | - | - | Stock Option | |
| Alliance Resource Partners, LP - Unit | Whelan J. Timothy | SENIOR VICE PRESIDENT SALES | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 99,010 | 0 | - | - | Restricted unit | |
| Alliance Resource Partners, LP - Unit | Whelan Timothy J. | SENIOR VICE PRESIDENT SALES | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 99,010 | 211,946 (0%) | 0% | - | Common unit | |
| Enterprise Products Partners L P - Unit | Boss R. Daniel | EVP-ACCTG, RISK CONTROL & IT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 97,000 | 97,000 | - | - | Phantom Units | |
| Enterprise Products Partners L P - Unit | Weitzel Harry P. | Director, EVP, GENERAL COUNSEL & SEC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 97,000 | 97,000 | - | - | Phantom Units | |
| Macrogenics Inc | Scott Koenig | Director, President and CEO | 08 Feb 2024 | 95,000 | 95,000 | - | - | Restricted Stock Unit | ||
| Immuneering Corp (Class A) | Bookman Michael D. | CHIEF LEGAL OFFICER, SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 93,000 | 93,000 | - | - | Stock Option | |
| 4D Molecular Therapeutics Inc | David Kirn | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 27.13 per share. | 08 Feb 2024 | 92,001 | 1,059,153 | - | 27.1 | 2,495,822 | Common Stock |
| Alkermes PLC | F. Pops Richard | Director, Director and CEO, Alkermes plc | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.77 per share. | 08 Feb 2024 | 91,757 | 1,179,675 (0%) | 0% | 26.8 | 2,456,335 | Ordinary Shares |
| Enterprise Products Partners L P - Unit | M. Christian Nelly | EVP-FIN/SUSTAIN. AND TREASURER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 91,000 | 91,000 | - | - | Phantom Units | |
| Enterprise Products Partners L P - Unit | Bacon Graham W. | EXECUTIVE VICE PRESIDENT & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 90,000 | 90,000 | - | - | Phantom Units | |
| Macrogenics Inc | Eric Risser | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 90,000 | 90,000 | - | - | Employee Stock Option (right to buy) | |
| Macrogenics Inc | L. Stephen Eck | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 90,000 | 90,000 | - | - | Employee Stock Option (right to buy) | |
| Macrogenics Inc | Bonvini Ezio | Sr VP, Research & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 90,000 | 90,000 | - | - | Employee Stock Option (right to buy) | |
| Palantir | Shyam Sankar | See Remarks | 08 Feb 2024 | 89,184 | 1,923,525 | - | - | Class B Common Stock | ||
| Palantir | Sankar Shyam | See Remarks | 08 Feb 2024 | 89,184 | 841,970 | - | - | Class A Common Stock | ||
| Palantir | Shyam Sankar | See Remarks | Sale of securities on an exchange or to another person at price $ 25.03 per share. | 08 Feb 2024 | 89,184 | 752,786 | - | 25.0 | 2,232,293 | Class A Common Stock |
| Palantir | Shyam Sankar | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 89,184 | 29,168 | - | - | Employee Stock Option (Right to buy) | |
| Palantir | Sankar Shyam | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 89,184 | 2,012,709 | - | - | Class B Common Stock | |
| Alliance Resource Partners, LP - Unit | Kirk Tholen | SENIOR VICE PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.58 per share. | 08 Feb 2024 | 87,624 | 110,396 (0%) | 0% | 20.6 | 1,803,302 | Common unit |
| Lazard Ltd (Class A) | Soto Alexandra | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 87,408 | 158,994 | - | - | Restricted Stock Unit | |
| Enterprise Products Partners L P - Unit | Secrest B. Brent | EVP & CHIEF COMMERCIAL OFFICER | 08 Feb 2024 | 87,000 | 87,000 | - | - | Phantom Units | ||
| Snowflake Inc (Class A) | Frank Slootman | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 225.13 per share. | 08 Feb 2024 | 86,078 | 180,143 | - | 225.1 | 19,378,740 | Class A Common Stock |
| Snowflake Inc (Class A) | Slootman Frank | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.88 per share. | 08 Feb 2024 | 86,078 | 266,221 | - | 8.9 | 764,373 | Class A Common Stock |
| Snowflake Inc (Class A) | Frank Slootman | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 86,078 | 10,809,286 | - | - | Stock Option (Right to Buy) | |
| BioRestorative Therapies Inc | Dale Broadrick | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.32 per share. | 08 Feb 2024 | 86,041 | 477,972 | - | 1.3 | 113,574 | Common Stock |
| Clover Health Investments Corp (Class A) | Andrew Toy | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.00 per share. | 08 Feb 2024 | 85,367 | 10,898,078 | - | 1 | 85,367 | Class A Common Stock |
| Kenvue | Mongon Thibaut | Director, Chief Executive Officer | 08 Feb 2024 | 82,877 | 96,638 | - | 19.7 | 1,630,191 | Common Stock | |
| RTX | J. Timm Stephen | President, Collins Aerospace | 08 Feb 2024 | 82,400 | 82,400 | - | - | Stock Appreciation Right | ||
| Royal Caribbean Cruises | Bayley W. Michael | Pres&CEO, Royal Caribbean Intl | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 81,045 | 175,436 (0%) | 0% | 0 | Common Stock | |
| Charles Schwab | Schwab Charles R. | Director, Co-Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Feb 2024 | 80,650 | 61,251,038 (4%) | 0% | 0 | Common Stock | |
| Macrogenics Inc | James Karrels | SVP, CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 80,000 | 80,000 | - | - | Employee Stock Option (right to buy) | |
| Viking Therapeutics Inc | Brian Lian | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 26.95 per share. | 08 Feb 2024 | 80,000 | 2,264,882 (3%) | 0% | 27.0 | 2,156,000 | Common Stock, par value $0.00001 per share |
| RTX | Gregory J. Hayes | Director, Chairman and CEO | 08 Feb 2024 | 79,533 | 566,723 (0%) | 0% | 91.0 | 7,240,684 | Common Stock | |
| Barnes Grp Inc | Hook J. Thomas | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 79,400 | 79,400 | - | - | Employee Stock Option-Right to Buy | |
| Alliance Resource Partners, LP - Unit | G. Sachse Robert | EXECUTIVE VICE PRESIDENT | 08 Feb 2024 | 79,210 | 0 | - | - | Restricted unit | ||
| Alliance Resource Partners, LP - Unit | Robert Sachse G. | EXECUTIVE VICE PRESIDENT | 08 Feb 2024 | 79,210 | 322,747 (0%) | 0% | - | Common unit | ||
| Union Pacific | Vincenzo Vena James | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 77,730 | 77,730 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ideaya Biosciences Inc | S. Yujiro Hata | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.31 per share. | 08 Feb 2024 | 75,815 | 753,702 (3%) | 0% | 4.3 | 326,763 | Common Stock |
| Ideaya Biosciences Inc | Yujiro Hata S. | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 45.15 per share. | 08 Feb 2024 | 75,815 | 677,887 (3%) | 0% | 45.1 | 3,422,835 | Common Stock |
| Ideaya Biosciences Inc | Yujiro Hata S. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 75,815 | 248,011 | - | - | Stock Option (right to buy) | |
| Zymeworks BC Inc | Cesano Alessandra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 74,000 | 74,000 | - | - | Stock Option (Right to Buy) | |
| BioRestorative Therapies Inc | Dale Broadrick | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.25 per share. | 08 Feb 2024 | 73,959 | 391,931 | - | 1.3 | 92,449 | Common Stock |
| Zurn Elkay Water Soln Corp | Mark Peterson W. | SVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 32.19 per share. | 08 Feb 2024 | 73,727 | 390,968 (0%) | 0% | 32.2 | 2,373,272 | Common Stock |
| GoPro Inc (Class A) | Brian Mcgee | EVP, CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 73,016 | 452,825 (0%) | 0% | 0 | Class A Common Stock | |
| Macrogenics Inc | Spitznagel Thomas | Sr VP, Technical Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 71,000 | 71,000 | - | - | Employee Stock Option (right to buy) | |
| Macrogenics Inc | Peters Stuart Jeffrey | Senior VP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 71,000 | 71,000 | - | - | Employee Stock Option (right to buy) | |
| Zurn Elkay Water Soln Corp | Peterson W. Mark | SVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 32.88 per share. | 08 Feb 2024 | 70,000 | 302,299 (0%) | 0% | 32.9 | 2,301,600 | Common Stock |
| Carrier Global | L. Gitlin David | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 67,250 | 0 | - | - | Stock Appreciation Right | |
| Carrier Global | Gitlin David L. | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.98 per share. | 08 Feb 2024 | 67,250 | 868,100 | - | 16.0 | 1,074,655 | Common Stock |
| nVent Electric PLC | A. Beth Wozniak | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 65,191 | 0 | - | - | Employee Stock Option (right to buy) | |
| nVent Electric PLC | Wozniak A. Beth | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.25 per share. | 08 Feb 2024 | 65,191 | 174,048 (0%) | 0% | 18.3 | 1,189,736 | Ordinary Shares |
| Biodesix Inc | Harper Cowie Robin | CFO, Secy & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 64,381 | 64,381 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 64,381 | 64,381 | - | - | Restricted Stock Units | |
| Biodesix Inc | Pestano Gary | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 64,381 | 64,381 | - | - | Restricted Stock Units | |
| Alliance Resource Partners, LP - Unit | Cary Marshall P. | SENIOR VP AND CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 64,160 | 1,013,263 (0%) | 0% | - | Common unit | |
| Alliance Resource Partners, LP - Unit | Marshall P. Cary | SENIOR VP AND CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 64,160 | 0 | - | - | Restricted unit | |
| RTX | Eddy G. Shane | President, P&W | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 64,100 | 64,100 | - | - | Stock Appreciation Right | |
| Priority Technology Holdings | Thomas Charles Priore | Director, President, CEO and Chairman, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 63,898 | 63,898 | - | - | Restricted Stock Unit | |
| Priority Technology Holdings | Thomas Charles Priore | Director, President, CEO and Chairman, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 63,898 | 33,983,384 (50%) | 0% | - | Common Stock | |
| CTS Corp | O'Sullivan Kieran | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 63,547 | 529,397 (1%) | 0% | 0 | Common Stock | |
| Warrior Met Coal Inc | Walter Scheller | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.39 per share. | 08 Feb 2024 | 63,002 | 351,912 (0%) | 0% | 60.4 | 3,804,691 | Common Stock |
| Adient PLC | Dorlack Jerome J. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 62,462 | 251,051 (0%) | 0% | - | Ordinary Shares | |
| Alliance Resource Partners, LP - Unit | Thomas Wynne M. | SENIOR VICE PRESIDENT AND COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.58 per share. | 08 Feb 2024 | 61,924 | 859,939 (0%) | 0% | 20.6 | 1,274,396 | Common unit |
| Immuneering Corp (Class A) | Morales Mallory | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 60,500 | 60,500 | - | - | Stock Option | |
| Immuneering Corp (Class A) | Brakewood Harold Eugene | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 60,500 | 60,500 | - | - | Stock Option | |
| Immuneering Corp (Class A) | Leah R. Neufeld | CHIEF PEOPLE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 60,500 | 60,500 | - | - | Stock Option | |
| Avista Corp | Vermillion P. Dennis | CEO | 08 Feb 2024 | 60,051 | 60,051 | - | - | Performance Shares Grant - 2024 | ||
| Aware Inc | AJ Nadell | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 60,000 | 60,000 | - | - | Unrestricted Stock Award | |
| Viking Therapeutics Inc | Brian Lian | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 25.95 per share. | 08 Feb 2024 | 60,000 | 2,344,882 (3%) | 0% | 26.0 | 1,557,000 | Common Stock, par value $0.00001 per share |
| Lexicon Pharma Inc | Kristen L. Alexander | VP, Finance and Accounting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 59,660 | 59,660 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharma Inc | Alexander L. Kristen | VP, Finance and Accounting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 59,660 | 59,660 | - | - | Restricted Stock Units | |
| Johnson & Johnson | Jennifer L. Taubert | EVP, WW Chair, Pharmaceuticals | Sale of securities on an exchange or to another person at price $ 156.27 per share. | 08 Feb 2024 | 59,397 | 141,416 (0%) | 0% | 156.3 | 9,281,969 | Common Stock |
| Johnson & Johnson | L. Taubert Jennifer | EVP, WW Chair, Pharmaceuticals | Exercise or conversion of derivative security received from the company (such as an option) at price $ 90.44 per share. | 08 Feb 2024 | 59,397 | 200,813 (0%) | 0% | 90.4 | 5,371,865 | Common Stock |
| Johnson & Johnson | L. Taubert Jennifer | EVP, WW Chair, Pharmaceuticals | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 59,397 | 0 | - | - | Employee Stock Options (Right to Buy) | |
| Priority Technology Holdings | Thomas Charles Priore | Director, President, CEO and Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 58,480 | 0 | - | - | Restricted Stock Unit | |
| Churchill Downs Inc | Carstanjen William C. | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 57,984 | 1,518,246 (3%) | 0% | 0 | Common Stock | |
| Union Pacific | Vena Vincenzo James | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 57,874 | 63,015 (0%) | 0% | 0 | Common Stock | |
| Cirrus Logic Inc | M. John Forsyth | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 57,629 | 57,629 | - | - | Non-Qualified Stock Option (right to buy) | |
| Royal Caribbean Cruises | Liberty T. Jason | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 56,732 | 201,422 (0%) | 0% | 0 | Common Stock | |
| IAC Inc - Ordinary Shares - New | Christopher Halpin | EVP, CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 56,486 | 67,826 | - | 0 | Common Stock, par value $0.0001 | |
| IAC Inc - Ordinary Shares - New | Christopher Halpin | EVP, CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 56,486 | 94,144 | - | - | Restricted Stock Units | |
| Frontier Grp Holdings Inc | L. Biffle Barry | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 56,280 | 904,663 | - | - | Common Stock | |
| Frontier Grp Holdings Inc | Biffle L. Barry | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 56,280 | 112,560 | - | - | Restricted Stock Units | |
| RTX | Williams M. Dantaya | EVP & Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 55,000 | 55,000 | - | - | Stock Appreciation Right | |
| RTX | Ramsaran Maharajh | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 55,000 | 55,000 | - | - | Stock Appreciation Right | |
| Evolv Tech Holdings Inc (Class A) | Ellenbogen Michael Philip | Director, Founder & Chief Innovation Ofc | Sale of securities on an exchange or to another person at price $ 5.04 per share. | 08 Feb 2024 | 54,873 | 1,975,473 | - | 5.0 | 276,560 | Class A Common Stock |
| Calix Inc | J. Cory Sindelar | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 54,500 | 54,500 | - | - | Stock Option (right to buy) | |
| Calix Inc | Michael Weening | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 54,500 | 54,500 | - | - | Stock Option (right to buy) | |
| Alliance Resource Partners, LP - Unit | R. Davis Eberley | SVP-LAW/ADMIN,GENERAL COUNSEL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.58 per share. | 08 Feb 2024 | 53,609 | 262,446 (0%) | 0% | 20.6 | 1,103,273 | Common unit |
| Hilton Worldwide | Nassetta Christopher J. | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.46 per share. | 08 Feb 2024 | 53,488 | 2,589,966 (0%) | 0% | 45.5 | 2,431,564 | Common Stock |
| Hilton Worldwide | Christopher J. Nassetta | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 53,488 | 0 | - | - | Employee Stock Option (right to buy) | |
| DraftKings Inc (Class A) | Stanton Dodge R. | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 52,777 | 314,807 | - | - | Stock Option | |
| DraftKings Inc (Class A) | Stanton R. Dodge | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.95 per share. | 08 Feb 2024 | 52,777 | 886,340 | - | 2.9 | 155,692 | Class A Common Stock |
| Biodesix Inc | Harper Cowie Robin | CFO, Secy & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 51,692 | 188,265 | - | - | Common Stock | |
| Cheniere Energy Inc | Fusco Jack A. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 50,677 | 50,677 | - | - | Restricted Stock Units | |
| Dolby Laboratories Inc (Class A) | John Couling D. | SVP, Entertainment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.98 per share. | 08 Feb 2024 | 50,000 | 158,519 (0%) | 0% | 43.0 | 2,149,000 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | John D. Couling | SVP, Entertainment | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 08 Feb 2024 | 50,000 | 108,519 (0%) | 0% | 80 | 4,000,000 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Couling John D. | SVP, Entertainment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 50,000 | 12,440 | - | - | Employee Stock Option (Right to Buy) | |
| Denali Therapeutics Inc | Alexander Schuth O. | COFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 50,000 | 145,078 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Alexander Schuth O. | COFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.68 per share. | 08 Feb 2024 | 50,000 | 210,185 (0%) | 0% | 0.7 | 34,000 | Common Stock |
| Ethan Allen Interiors Inc | Kathwari M. Farooq | Director, Chairman, President & CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 30.40 per share. | 08 Feb 2024 | 50,000 | 1,735,193 (6%) | 0% | 30.4 | 1,520,000 | Common Stock |
| Select Medical Holdings Corp | A. Ortenzio Robert | Director, EXECUTIVE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 26.00 per share. | 08 Feb 2024 | 50,000 | 6,789,668 (5%) | 0% | 26 | 1,300,000 | Common Stock |
| Compass Therapeutics Inc | Bisker-Leib Vered | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.45 per share. | 08 Feb 2024 | 49,198 | 3,124,426 | - | 1.4 | 71,337 | Common Stock |
| Viking Therapeutics Inc | Lian Brian | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 25.75 per share. | 08 Feb 2024 | 49,079 | 2,264,882 (3%) | 0% | 25.7 | 1,263,784 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Lian Brian | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.23 per share. | 08 Feb 2024 | 49,079 | 2,313,961 (3%) | 0% | 1.2 | 60,367 | Common Stock, par value $0.00001 per share |
| Biodesix Inc | Harper Cowie Robin | CFO, Secy & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 48,535 | 145,606 | - | - | Restricted Stock Units | |
| Warrior Met Coal Inc | Richardson Jack K. | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 47,812 | 172,964 (0%) | 0% | 0 | Common Stock | |
| Mueller Ind Inc | Martin Jeffrey A. | EVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 49.25 per share. | 08 Feb 2024 | 47,280 | 370,840 (0%) | 0% | 49.3 | 2,328,587 | Common Stock |
| Usana Health Sciences Inc | Brown Jim | CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 47,198 | 76,960 | - | - | Restricted Stock Units | |
| Carrier Global | David Gitlin L. | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.53 per share. | 08 Feb 2024 | 46,819 | 914,919 | - | 18.5 | 867,556 | Common Stock |
| Carrier Global | David L. Gitlin | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 46,819 | 0 | - | - | Stock Appreciation Right | |
| Vornado Realty Trust | Michael Franco | PRESIDENT AND CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 46,714 | 46,714 | - | - | LTIP Units | |
| Alkermes PLC | Hopkinson C. Craig | EVP R&D, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 46,658 | 103,217 (0%) | 0% | - | Ordinary Shares | |
| QuidelOrtho Corporation | Bryant Douglas C. | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 46,254 | 46,254 | - | - | Restricted Stock Units | |
| Macrogenics Inc | Cilinski Lynn | VP, Controller and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 45,000 | 45,000 | - | - | Employee Stock Option (right to buy) | |
| Mereo Biopharma Grp PLC (ADR) | Anders Olof Adolf Ekblom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 45,000 | 45,000 | - | - | Share Options (Right to buy) | |
| Mereo Biopharma Grp PLC (ADR) | Rachel Pakianathan Deepika | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 45,000 | 45,000 | - | - | Share Options (Right to buy) | |
| Mereo Biopharma Grp PLC (ADR) | Stephen Michael Wyzga | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 45,000 | 45,000 | - | - | Share Options (Right to buy) | |
| Mereo Biopharma Grp PLC (ADR) | Pierre Jacquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 45,000 | 45,000 | - | - | Share Options (Right to buy) | |
| Mereo Biopharma Grp PLC (ADR) | Mary Jenkins Annalisa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 45,000 | 45,000 | - | - | Share Options (Right to buy) | |
| Mereo Biopharma Grp PLC (ADR) | Daniel Shames | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 45,000 | 45,000 | - | - | Share Options (Right to buy) | |
| Mereo Biopharma Grp PLC (ADR) | Bender Jeremy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 45,000 | 45,000 | - | - | Share Options (Right to buy) | |
| Mereo Biopharma Grp PLC (ADR) | Marc J. Yoskowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 45,000 | 45,000 | - | - | Share Options (Right to buy) | |
| Timken Co. | Kyle Richard | Director, President and CEO | 08 Feb 2024 | 45,000 | 45,000 | - | - | Restricted Share Unit | ||
| Snap Inc (Class A) | Murphy Robert | Director, Chief Technology Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Feb 2024 | 44,798 | 65,894,865 (5%) | 0% | 0 | Class A Common Stock | |
| Compass Therapeutics Inc | J. Thomas Schuetz | Director, PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.45 per share. | 08 Feb 2024 | 44,782 | 6,570,566 | - | 1.5 | 64,934 | Common Stock |
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 08 Feb 2024 | 44,770 | 682,770 (0%) | 0% | 0 | Class A Common Stock | ||
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 08 Feb 2024 | 44,770 | 1,177,866 | - | - | Class B Common Stock | ||
| Alliance Resource Partners, LP - Unit | Timothy Whelan J. | SENIOR VICE PRESIDENT SALES | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.58 per share. | 08 Feb 2024 | 44,000 | 167,946 (0%) | 0% | 20.6 | 905,520 | Common unit |
| Vornado Realty Trust | Weiss J. Glenn | EVP- OFF. LEASING CO HEAD R.E. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 43,290 | 43,290 | - | - | LTIP Units | |
| Graco Inc | David M. Lowe | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.93 per share. | 08 Feb 2024 | 43,080 | 645,202 (0%) | 0% | 24.9 | 1,074,131 | Common Stock |
| Graco Inc | David M. Lowe | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 43,080 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Royal Caribbean Cruises | Liberty T. Jason | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 42,997 | 244,419 (0%) | 0% | 0 | Common Stock | |
| Hilltop Holdings Inc | B. Jeremy Ford | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 42,565 | 1,401,797 (1%) | 0% | 0 | Common Stock | |
| RTX | J. Stephen Timm | President, Collins Aerospace | 08 Feb 2024 | 41,428 | 58,496 (0%) | 0% | 91.0 | 3,771,605 | Common Stock | |
| RTX | Christopher T. Calio | Director, President and COO | Grant, award, or other acquisition of securities at price $ 91.04 per share. | 08 Feb 2024 | 41,428 | 93,735 (0%) | 0% | 91.0 | 3,771,605 | Common Stock |
| Ironwood Pharma Inc (Class A) | Emany K. Sravan | SVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.90 per share. | 08 Feb 2024 | 41,332 | 225,737 (0%) | 0% | 14.9 | 615,847 | Class A Common Stock |
| RTX | J. Gregory Hayes | Director, Chairman and CEO | 08 Feb 2024 | 41,298 | 663,192 (0%) | 0% | 0 | Common Stock | ||
| RTX | J. Gregory Hayes | Director, Chairman and CEO | 08 Feb 2024 | 41,298 | 0 | - | - | Restricted Stock Units | ||
| Warrior Met Coal Inc | Boyles W. Dale | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 40,759 | 156,280 (0%) | 0% | 0 | Common Stock | |
| Viking Therapeutics Inc | Lian Brian | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 27.45 per share. | 08 Feb 2024 | 40,000 | 2,224,882 (3%) | 0% | 27.5 | 1,098,000 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Lian Brian | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 28.90 per share. | 08 Feb 2024 | 40,000 | 2,184,882 (3%) | 0% | 28.9 | 1,156,000 | Common Stock, par value $0.00001 per share |
| Carrier Global | L. Gitlin David | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.24 per share. | 08 Feb 2024 | 39,158 | 954,077 | - | 19.2 | 753,400 | Common Stock |
| Carrier Global | Gitlin David L. | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 39,158 | 0 | - | - | Stock Appreciation Right | |
| DraftKings Inc (Class A) | Robins D. Jason | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 38,217 | 305,734 | - | - | Restricted Stock Units | |
| DraftKings Inc (Class A) | Jason D. Robins | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 38,217 | 3,411,854 | - | - | Class A Common Stock | |
| Vornado Realty Trust | S. Langer Barry | EVP - DEV. CO-HEAD OF R.E. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 37,548 | 37,548 | - | - | LTIP Units | |
| Blackstone | John Finley | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 127.81 per share. | 08 Feb 2024 | 37,495 | 404,648 (0%) | 0% | 127.8 | 4,792,236 | Common Stock |
| Alkermes PLC | Blair C. Jackson | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 36,835 | 150,952 (0%) | 0% | - | Ordinary Shares | |
| Sensient Tech Corp | Manning Paul | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 36,005 | 243,357 (0%) | 0% | 0 | Common Stock | |
| Sensient Tech Corp | Manning Paul | Director, Chairman, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 36,005 | 0 | - | - | Performance Stock Unit | |
| Tvardi Therapeutics Inc | Christopher A. Posner | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 0.53 per share. | 08 Feb 2024 | 35,575 | 186,355 (0%) | 0% | 0.5 | 18,855 | Common Stock |
| Alliance Resource Partners, LP - Unit | G. Sachse Robert | EXECUTIVE VICE PRESIDENT | 08 Feb 2024 | 35,302 | 287,445 (0%) | 0% | 20.6 | 726,515 | Common unit | |
| Weyerhaeuser | Russell Hagen S. | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 35,183 | 322,036 (0%) | 0% | 0 | Common | |
| Biodesix Inc | Christopher Vazquez | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 34,966 | 34,966 | - | - | Stock Options (Right to buy) | |
| Viking Therapeutics Inc | Brian Lian | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 34,931 | 0 | - | - | Stock Option (right to buy) | |
| PotlatchDeltic Corp | Cremers J. Eric | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 34,743 | 232,885 (0%) | 0% | 0 | Common Stock | |
| Biodesix Inc | Hutton Scott | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 1.92 per share. | 08 Feb 2024 | 34,682 | 494,719 | - | 1.9 | 66,472 | Common Stock |
| Weyerhaeuser | Keith ORear | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 34,293 | 175,323 (0%) | 0% | 0 | Common | |
| Dolby Laboratories Inc (Class A) | John Couling D. | SVP, Entertainment | Sale of securities on an exchange or to another person at price $ 80.81 per share. | 08 Feb 2024 | 33,560 | 108,519 (0%) | 0% | 80.8 | 2,711,896 | Class A Common Stock |
| Macrogenics Inc | Ezio Bonvini | Sr VP, Research & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 33,500 | 33,500 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | L. Eck Stephen | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 33,500 | 33,500 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Risser Eric | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 33,500 | 33,500 | - | - | Restricted Stock Unit | |
| LanzaTech Global Inc (Class A) | Gary E. Rieschel | Director | 08 Feb 2024 | 32,467 | 32,467 | - | - | Restricted Stock Units | ||
| LanzaTech Global Inc (Class A) | Barbara M. Byrne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 32,467 | 32,467 | - | - | Restricted Stock Units | |
| LanzaTech Global Inc (Class A) | Dorri McWhorter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 32,467 | 32,467 | - | - | Restricted Stock Units | |
| LanzaTech Global Inc (Class A) | Nigel Gormly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 32,467 | 32,467 | - | - | Restricted Stock Units | |
| LanzaTech Global Inc (Class A) | James Messina | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 32,467 | 32,467 | - | - | Restricted Stock Units | |
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 32,024 | 79,736 | - | - | Common Stock | |
| Priority Technology Holdings | Crisafulli Marc A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 31,949 | 31,949 | - | - | Restricted Stock Unit | |
| Priority Technology Holdings | C. Marietta Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 31,949 | 31,949 | - | - | Restricted Stock Unit | |
| Priority Technology Holdings | M. Christina Favilla | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 31,949 | 31,949 | - | - | Restricted Stock Unit | |
| Priority Technology Holdings | K. Passilla Michael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 31,949 | 31,949 | - | - | Restricted Stock Unit | |
| Priority Technology Holdings | Vito Priore John | Director, Ten Percent Owner | 08 Feb 2024 | 31,949 | 31,949 | - | - | Restricted Stock Unit | ||
| GoodRx Holdings Inc (Class A) | Beri Raj | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 31,657 | 411,538 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc (Class A) | Raj Beri | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 31,657 | 335,859 | - | - | Class A Common Stock | |
| Weyerhaeuser | T. Harlan Kristy | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 31,621 | 175,518 (0%) | 0% | 0 | Common | |
| Yum China Holdings Inc | Andy Yeung | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 31,526 | 31,526 | - | - | Restricted Stock Unit | |
| IAC Inc - Ordinary Shares - New | Christopher Halpin | EVP, CFO & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.25 per share. | 08 Feb 2024 | 31,337 | 36,489 | - | 51.2 | 1,606,021 | Common Stock, par value $0.0001 |
| Louisiana-Pacific Corp | Southern William Bradley | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 31,337 | 561,565 (0%) | 0% | 0 | Common Stock | |
| GoPro Inc (Class A) | Saltman T. Eve | SVP, Corp/Bus Dev, CLO, Sec | 08 Feb 2024 | 31,032 | 243,960 (0%) | 0% | 0 | Class A Common Stock | ||
| GoPro Inc (Class A) | Dean Jahnke | SVP, Global Sales, CM, RE | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 31,032 | 318,676 (0%) | 0% | 0 | Class A Common Stock | |
| Bowman Consulting Grp Ltd | J. Labovitz Bruce | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 30,838 | 296,776 | - | 0 | Common Stock | |
| Mereo Biopharma Grp PLC (ADR) | Stephen Michael Wyzga | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 30,783 | 30,783 | - | - | Deferred Restricted Stock Units | |
| Weyerhaeuser | Denise M. Merle | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 30,729 | 171,422 (0%) | 0% | 0 | Common | |
| Gitlab Inc (Class A) | Schulman J. Robin | Chief Legal Officer & Corp Sec | Sale of securities on an exchange or to another person at price $ 75.11 per share. | 08 Feb 2024 | 30,543 | 60,132 | - | 75.1 | 2,294,085 | Class A Common Stock |
| Gitlab Inc (Class A) | Schulman J. Robin | Chief Legal Officer & Corp Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 30,543 | 46,255 | - | - | Stock Option (Right to buy Class B Common Stock) | |
| Gitlab Inc (Class A) | Schulman J. Robin | Chief Legal Officer & Corp Sec | 08 Feb 2024 | 30,543 | 0 | - | - | Class B Common Stock | ||
| Gitlab Inc (Class A) | J. Schulman Robin | Chief Legal Officer & Corp Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 30,543 | 30,543 | - | - | Class B Common Stock | |
| Gitlab Inc (Class A) | Schulman Robin J. | Chief Legal Officer & Corp Sec | 08 Feb 2024 | 30,543 | 90,675 | - | 0 | Class A Common Stock | ||
| Biodesix Inc | Kieran O’Kane | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 30,534 | 91,601 | - | - | Restricted Stock Units | |
| Kenvue | Meredith Stevens | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 30,099 | 0 | - | - | Restricted Stock Units | |
| Kenvue | Stevens Meredith | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 30,099 | 30,099 | - | 0 | Common Stock | |
| Enova Intl Inc | David Fisher A. | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 30,000 | 1,104,280 | - | - | Non-Qualified Stock Option (right to buy) with limited SAR | |
| Hilltop Holdings Inc | Ford Gerald J. | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 30,000 | 316,130 (0%) | 0% | 0 | Common Stock | |
| Macrogenics Inc | Karrels James | SVP, CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 30,000 | 30,000 | - | - | Restricted Stock Unit | |
| Timken Co. | Kyle Richard | Director, President and CEO | 08 Feb 2024 | 30,000 | 30,000 | - | - | Restricted Share Unit | ||
| Biodesix Inc | Scott Hutton | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 1.66 per share. | 08 Feb 2024 | 29,708 | 465,011 | - | 1.7 | 49,455 | Common Stock |
| Biodesix Inc | Pestano Gary | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 29,633 | 134,134 | - | - | Common Stock | |
| Warrior Met Coal Inc | Gant K. Kelli | CHIEF ADMINISTRATIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 29,605 | 81,637 (0%) | 0% | 0 | Common Stock | |
| Weatherford Intl PLC - Ordinary Shares - New | Weatherholt Scott C. | EVP, GC & CCO | Sale of securities on an exchange or to another person at price $ 99.05 per share. | 08 Feb 2024 | 29,439 | 126,631 (0%) | 0% | 99.1 | 2,916,045 | Ordinary Shares |
| Palantir | Sankar Shyam | See Remarks | 08 Feb 2024 | 29,168 | 1,923,525 | - | - | Class B Common Stock | ||
| Palantir | Shyam Sankar | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 29,168 | 0 | - | - | Employee Stock Option (Right to buy) | |
| Palantir | Sankar Shyam | See Remarks | 08 Feb 2024 | 29,168 | 781,954 | - | - | Class A Common Stock | ||
| Palantir | Sankar Shyam | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 29,168 | 1,952,693 | - | - | Class B Common Stock | |
| Palantir | Shyam Sankar | See Remarks | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 08 Feb 2024 | 29,168 | 752,786 | - | 25.0 | 729,276 | Class A Common Stock |
| nVent Electric PLC | Beth A. Wozniak | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 64.79 per share. | 08 Feb 2024 | 29,064 | 342 (0%) | 0% | 64.8 | 1,882,969 | Ordinary Shares |
| Barnes Grp Inc | Thomas J. Hook | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 28,800 | 251,390 (0%) | 0% | 0 | Common Stock | |
| Kenvue | Ellie Bing Xie | Group President APAC | 08 Feb 2024 | 28,781 | 28,781 | - | 0 | Common Stock | ||
| Kenvue | Ellie Bing Xie | Group President APAC | 08 Feb 2024 | 28,781 | 0 | - | - | Restricted Stock Units | ||
| ASGN Inc | Theodore Hanson S. | Director, CEO | Grant, award, or other acquisition of securities at price $ 95.57 per share. | 08 Feb 2024 | 28,703 | 347,462 (0%) | 0% | 95.6 | 2,743,146 | Common Stock |
| Alliance Resource Partners, LP - Unit | Marshall Cary P. | SENIOR VP AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.58 per share. | 08 Feb 2024 | 28,640 | 984,623 (0%) | 0% | 20.6 | 589,411 | Common unit |
| Host Hotels & Resorts - REIT | Risoleo James F. | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.55 per share. | 08 Feb 2024 | 28,413 | 1,902,707 (0%) | 0% | 19.5 | 555,474 | Common Stock |
| Biodesix Inc | Gary Pestano | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 28,255 | 84,766 | - | - | Restricted Stock Units | |
| Alkermes PLC | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 28,240 | 156,190 (0%) | 0% | - | Ordinary Shares | |
| CTS Corp | O'Sullivan Kieran | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.19 per share. | 08 Feb 2024 | 28,238 | 501,159 (1%) | 0% | 44.2 | 1,247,837 | Common Stock |
| Kenvue | Ruh Paul | Chief Financial Officer | 08 Feb 2024 | 27,877 | 0 | - | - | Restricted Stock Units | ||
| Kenvue | Paul Ruh | Chief Financial Officer | 08 Feb 2024 | 27,877 | 27,877 | - | 0 | Common Stock | ||
| Churchill Downs Inc | C. Carstanjen William | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 27,645 | 429,667 | - | - | Restricted Stock Units | |
| Gartner | Eugene Hall A. | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 27,291 | 27,291 | - | - | Stock Appreciation Rights | |
| Alkermes PLC | M. Iain Brown | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 27,012 | 109,850 (0%) | 0% | - | Ordinary Shares | |
| Alkermes PLC | Todd Christian Nichols | SVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 27,012 | 69,941 (0%) | 0% | - | Ordinary Shares | |
| Macrogenics Inc | Jeffrey Stuart Peters | Senior VP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 27,000 | 27,000 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Spitznagel Thomas | Sr VP, Technical Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 27,000 | 27,000 | - | - | Restricted Stock Unit | |
| Weyerhaeuser | M. Wold David | Senior Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 26,876 | 90,024 (0%) | 0% | 0 | Common | |
| Host Hotels & Resorts - REIT | James F. Risoleo | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.55 per share. | 08 Feb 2024 | 26,751 | 1,905,990 (0%) | 0% | 19.5 | 522,982 | Common Stock |
| Weyerhaeuser | Keith ORear | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 26,694 | 202,017 (0%) | 0% | 0 | Common | |
| Weyerhaeuser | Russell S. Hagen | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 26,574 | 348,610 (0%) | 0% | 0 | Common | |
| Carrier Global | OConnor Kevin J. | Senior VP & CLO | Sale of securities on an exchange or to another person at price $ 53.77 per share. | 08 Feb 2024 | 26,551 | 66,083 | - | 53.8 | 1,427,676 | Common Stock |
| Churchill Downs Inc | William E. Mudd | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 26,360 | 637,499 (1%) | 0% | 0 | Common Stock | |
| nVent Electric PLC | Beth A. Wozniak | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.65 per share. | 08 Feb 2024 | 26,326 | 108,857 (0%) | 0% | 16.7 | 438,328 | Ordinary Shares |
| nVent Electric PLC | Wozniak Beth A. | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 26,326 | 6,063 | - | - | Employee Stock Option (right to buy) | |
| Graco Inc | David M. Lowe | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.30 per share. | 08 Feb 2024 | 26,235 | 618,967 (0%) | 0% | 87.3 | 2,290,316 | Common Stock |
| KKR Real Estate Finance Trust Inc | A. Matthew Salem | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 9.72 per share. | 08 Feb 2024 | 26,000 | 460,309 (0%) | 0% | 9.7 | 252,834 | Common Stock |
| Churchill Downs Inc | William C. Carstanjen | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 123.00 per share. | 08 Feb 2024 | 25,977 | 1,492,269 (3%) | 0% | 123 | 3,195,171 | Common Stock |
| Union Pacific | F. Elizabeth Whited | PRESIDENT | 08 Feb 2024 | 25,911 | 25,911 | - | - | Non-Qualified Stock Option (right to buy) | ||
| PotlatchDeltic Corp | Eric J. Cremers | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 25,816 | 258,701 (0%) | 0% | 0 | Common Stock | |
| Avista Corp | Vermillion Dennis P. | CEO | 08 Feb 2024 | 25,734 | 164,889 | - | 32.6 | 839,958 | Common Stock - Restricted Shares Grant 2024 | |
| Weyerhaeuser | Travis Keatley A. | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 25,366 | 110,568 (0%) | 0% | 0 | Common | |
| CTS Corp | O'Sullivan Kieran | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 25,344 | 526,503 (1%) | 0% | 0 | Common Stock | |
| Enova Intl Inc | Fisher David A. | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.54 per share. | 08 Feb 2024 | 25,326 | 474,063 (1%) | 0% | 55.5 | 1,406,606 | Common Stock, par value $0.00001 |
| Bowman Consulting Grp Ltd | Robert Hickey | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 25,095 | 217,148 | - | 0 | Common Stock | |
| Cirrus Logic Inc | Forsyth M. John | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 25,026 | 75,414 | - | - | Restricted Stock Units | |
| Onto Innovation Inc | Michael Plisinski P. | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 24,834 | 272,596 (0%) | 0% | 0 | Common Stock | |
| Frontier Grp Holdings Inc | L. Biffle Barry | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.89 per share. | 08 Feb 2024 | 24,622 | 880,041 | - | 6.9 | 169,646 | Common Stock |
| nVent Electric PLC | A. Beth Wozniak | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.57 per share. | 08 Feb 2024 | 24,505 | 198,553 (0%) | 0% | 19.6 | 479,563 | Ordinary Shares |
| nVent Electric PLC | Wozniak A. Beth | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 24,505 | 1,718 | - | - | Employee Stock Option (right to buy) | |
| Frontier Grp Holdings Inc | Dempsey James G. | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 24,150 | 621,508 | - | - | Common Stock | |
| Frontier Grp Holdings Inc | G. James Dempsey | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 24,150 | 48,300 | - | - | Restricted Stock Units | |
| Warrior Met Coal Inc | Charles Lussier | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 24,011 | 65,746 (0%) | 0% | 0 | Common Stock | |
| Bowman Consulting Grp Ltd | Bruen Michael | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 23,963 | 437,627 | - | 0 | Common Stock | |
| RTX | M. Dantaya Williams | EVP & Chief HR Officer | Grant, award, or other acquisition of securities at price $ 91.04 per share. | 08 Feb 2024 | 23,674 | 33,124 (0%) | 0% | 91.0 | 2,155,281 | Common Stock |
| Dover | Brad M. Cerepak | Senior VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 23,595 | 23,595 | - | - | Stock Appreciation Right | |
| Ideaya Biosciences Inc | Yujiro S. Hata | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 45.54 per share. | 08 Feb 2024 | 23,557 | 677,887 (3%) | 0% | 45.5 | 1,072,715 | Common Stock |
| Ideaya Biosciences Inc | Yujiro S. Hata | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.31 per share. | 08 Feb 2024 | 23,557 | 701,444 (3%) | 0% | 4.3 | 101,531 | Common Stock |
| Ideaya Biosciences Inc | Yujiro Hata S. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 23,557 | 224,454 | - | - | Stock Option (right to buy) | |
| Kenvue | Thibaut Mongon | Director, Chief Executive Officer | 08 Feb 2024 | 23,432 | 0 | - | - | Restricted Stock Units | ||
| Kenvue | Mongon Thibaut | Director, Chief Executive Officer | 08 Feb 2024 | 23,432 | 120,070 | - | 0 | Common Stock | ||
| Manitowoc Co. Inc | H. Ravenscroft Aaron | President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.04 per share. | 08 Feb 2024 | 23,125 | 319,881 (0%) | 0% | 17.0 | 394,050 | Common Stock |
| Evercore Inc (Class A) | Roger Altman C. | Director, Founder and Senior Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Feb 2024 | 23,000 | 64,087 (0%) | 0% | 0 | Shares of Class A common stock, par value $0.01 per share | |
| A.O. Smith | Kevin J. Wheeler | Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 22,790 | 94,253 (0%) | 0% | 0 | Common Stock | |
| A.O. Smith | J. Kevin Wheeler | Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 22,790 | 0 | - | - | Restricted Stock Units | |
| Weyerhaeuser | Harlan Kristy T. | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 22,648 | 198,166 (0%) | 0% | 0 | Common | |
| AST SpaceMobile Inc (Class A) | Brian Heller | EVP, GC & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.18 per share. | 08 Feb 2024 | 22,603 | 161,719 | - | 3.2 | 71,878 | Class A Common Stock |
| Goosehead Insurance Inc (Class A) | Coleman Desiree | Ten Percent Owner, Member of 10% owner group | 08 Feb 2024 | 21,654 | 200,000 (1%) | 0% | 0 | Class B Common Stock | ||
| Goosehead Insurance Inc (Class A) | Coleman Desiree | Ten Percent Owner, Member of 10% owner group | 08 Feb 2024 | 21,654 | 21,654 (0%) | 0% | 0 | Class A Common Stock | ||
| Goosehead Insurance Inc (Class A) | Desiree Coleman | Ten Percent Owner, Member of 10% owner group | 08 Feb 2024 | 21,654 | 200,000 | - | - | LLC Units in Goosehead Financial, LLC | ||
| Hilton Worldwide | J. Christopher Nassetta | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 192.82 per share. | 08 Feb 2024 | 21,595 | 2,568,371 (0%) | 0% | 192.8 | 4,163,896 | Common Stock |
| Balchem Corp | Theodore L. Harris | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 21,500 | 21,500 | - | - | Stock Option | |
| Hilton Worldwide | J. Nassetta Christopher | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.46 per share. | 08 Feb 2024 | 21,489 | 2,557,967 (0%) | 0% | 45.5 | 976,890 | Common Stock |
| Hilton Worldwide | Christopher J. Nassetta | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 21,489 | 53,488 | - | - | Employee Stock Option (right to buy) | |
| Alkermes PLC | J. Michael Landine | SVP, Corp Dev., Alkermes, Inc. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 21,485 | 271,927 (0%) | 0% | - | Ordinary Shares | |
| Weyerhaeuser | Denise Merle M. | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 21,440 | 192,862 (0%) | 0% | 0 | Common | |
| Kenvue | Tillett Caroline | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 21,321 | 21,321 | - | 0 | Common Stock | |
| Kenvue | Caroline Tillett | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 21,321 | 0 | - | - | Restricted Stock Units | |
| Dover | J. Richard Tobin | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 21,220 | 219,691 (0%) | 0% | 0 | Common Stock | |
| Dolby Laboratories Inc (Class A) | D. John Couling | SVP, Entertainment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.32 per share. | 08 Feb 2024 | 21,120 | 142,079 (0%) | 0% | 62.3 | 1,316,198 | Class A Common Stock |
| Dolby Laboratories Inc (Class A) | Couling D. John | SVP, Entertainment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 21,120 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Balchem Corp | Harris L. Theodore | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 20,639 | 111,311 (0%) | 0% | 0 | Common Stock | |
| FirstCash Holdings Inc | Douglas Rippel R. | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 116.32 per share. | 08 Feb 2024 | 20,518 | 5,926,131 (14%) | 0% | 116.3 | 2,386,654 | Common Stock |
| FirstCash Holdings Inc | R. Douglas Rippel | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 117.81 per share. | 08 Feb 2024 | 20,499 | 5,905,632 (14%) | 0% | 117.8 | 2,414,987 | Common Stock |
| Hilltop Holdings Inc | Bradley M. Winges | Hilltop Securities CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 20,385 | 128,933 (0%) | 0% | 0 | Common Stock | |
| Warrior Met Coal Inc | Jack K. Richardson | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.39 per share. | 08 Feb 2024 | 20,231 | 152,733 (0%) | 0% | 60.4 | 1,221,750 | Common Stock |
| FirstCash Holdings Inc | Rippel Douglas R. | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 118.91 per share. | 08 Feb 2024 | 20,025 | 5,885,607 (14%) | 0% | 118.9 | 2,381,173 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.